FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Carlos Campo

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Julian Segura; Carlos Campo; Luis M Ruilope; José L Rodicio
Do we need to target 'prediabetic' hypertensive patients?
Carlos Campo; Jesús Saavedra; Julian Segura; Cecilia Roldán; Luis M Ruilope; G Parati
Correlations of smoothness index and trough-to-peak ratio with left ventricular mass index changes induced by lercanidipine in hypertensive patients. A pilot trial.
Carlos Campo; Cecilia Roldán; Julian Segura
[Primary prevention of arterial HT: real possibility or utopia? Early detection of arterial HT].

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Carlos Campo (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2005: Julian Segura; Carlos Campo; Luis M Ruilope; José L Rodicio
Do we need to target 'prediabetic' hypertensive patients?
Journal of hypertension 2005;23(12):2119-25.
2005: Carlos Campo; Jesús Saavedra; Julian Segura; Cecilia Roldán; Luis M Ruilope; G Parati
Correlations of smoothness index and trough-to-peak ratio with left ventricular mass index changes induced by lercanidipine in hypertensive patients. A pilot trial.
Minerva medica 2005;96(5):365-71.
2005: Carlos Campo; Cecilia Roldán; Julian Segura
[Primary prevention of arterial HT: real possibility or utopia? Early detection of arterial HT].
Nefrología : publicación oficial de la Sociedad Española Nefrologia 2005;25 Suppl 4():7-12.
2005: Julian Segura; Carlos Campo; Luis M Ruilope
Influence of chronic kidney disease development and renin-angiotensin system inhibition on cardiovascular prognosis.
Current medicinal chemistry. Cardiovascular and hematological agents 2005;3(1):55-60.
2004: Julian Segura; Carlos Campo; Luis M Ruilope
Effect of proteinuria and glomerular filtration rate on cardiovascular risk in essential hypertension.
Kidney international. Supplement 2004;(92):S45-9.
2004: Julian Segura; Carlos Campo; Luis M Ruilope
Chronic kidney disease and global cardiovascular risk in essential hypertension.
Minerva medica 2004;95(5):375-83.
2004: Julian Segura; Carlos Campo; José A García Donaire; Luis M Ruilope
Development of chronic kidney disease in essential hypertension during long-term therapy.
Current opinion in nephrology and hypertension 2004;13(5):495-500.
2004: Julian Segura; Carlos Campo; Paloma Gil; Cecilia Roldán; Luis Vigil; José L Rodicio; Luis M Ruilope
Development of chronic kidney disease and cardiovascular prognosis in essential hypertensive patients.
Journal of the American Society of Nephrology : JASN 2004;15(6):1616-22.
2004: José R Banegas; Julian Segura; Luis M Ruilope; Manuel Luque; Rafael García Robles; Carlos Campo; Fernando Rodríguez Artalejo; Juan Tamargo
Blood pressure control and physician management of hypertension in hospital hypertension units in Spain.
Hypertension 2004;43(6):1338-44.
2004: Alejandro de la Sierra; Blas Gil-Extremera; Carlos Calvo; Carlos Campo; Juan García-Puig; E Márquez; J Oliván; A Roca Cusachs; S Sanz de Castro; Caridad Pontes; Joaquin Delgadillo
Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients.
Journal of human hypertension 2004;18(3):215-22.
2004: Julian Segura; Carlos Campo; Cecilia Roldán; Helle Christiansen; Luis Vigil; Rafael García Robles; José L Rodicio; Luis M Ruilope
Hypertensive renal damage in metabolic syndrome is associated with glucose metabolism disturbances.
Journal of the American Society of Nephrology : JASN 2004;15 Suppl 1():S37-42.
2003: Carlos Campo; Julian Segura; Cecilia Roldán; José M Alcázar; José L Rodicio; Luis M Ruilope
Doxazosin GITS versus hydrochlorothiazide as add-on therapy in patients with uncontrolled hypertension.
Blood pressure. Supplement 2003;2():16-21.
2003: Julian Segura; Helle Christiansen; Carlos Campo; Luis M Ruilope
How to titrate ACE inhibitors and angiotensin receptor blockers in renal patients: according to blood pressure or proteinuria?
Current hypertension reports 2003;5(5):426-9.
2003: Luis M Ruilope; Julian Segura; Carlos Campo; José L Rodicio
Renal participation in cardiovascular risk in essential hypertension.
Expert review of cardiovascular therapy 2003;1(2):309-15.
2003: Juliá Segura; Manuel Praga; Carlos Campo; José L Rodicio; Luis M Ruilope
Combination is better than monotherapy with ACE inhibitor or angiotensin receptor antagonist at recommended doses.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2003;4(1):43-7.
2003: Carlos Campo; Luis M Ruilope; Julian Segura; José L Rodicio; Rafael García Robles; Juan Garcia-Puig
Hyperuricemia, low urine urate excretion and target organ damage in arterial hypertension.
Blood pressure 2003;12(5-6):277-83.
2002: Julian Segura; Carlos Campo; Luis M Ruilope
Proteinuria: an underappreciated risk factor in cardiovascular disease.
Current cardiology reports 2002;4(6):458-62.
2002: Julían Segura; Carlos Campo; Luis M Ruilope
How relevant and frequent is the presence of mild renal insufficiency in essential hypertension?
Journal of clinical hypertension (Greenwich, Conn.) 2002;4(5):332-6.
2002: Julian Segura; Carlos Campo; Luis M Ruilope
Antihypertensive therapy and progression of renal failure.
Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia 2002;13(3):266-72.
2001: Luis M Ruilope; Carlos Campo; Julian Segura
The calcium channel blocker controversy in patients with diabetic nephropathy: Is there an issue?
Current hypertension reports 2001;3(5):419-21.
2001: Julian Segura; Carlos Campo; José L Rodicio; Luis M Ruilope
ACE inhibitors and appearance of renal events in hypertensive nephrosclerosis.
Hypertension 2001;38(3 Pt 2):645-9.
2001: Carlos Campo; Juan García-Puig; Julian Segura; J María Alcázar; Rafael García Robles; Luis M Ruilope
[Relationship between severity of essential arterial hypertension and the prevalence hyperuricemia].
Medicina clínica 2001;117(3):85-9.
2001: Carlos Campo; Julian Segura; M L Fernández; L Guerrero; H Christiansen; Luis M Ruilope
A prospective comparison of four antihypertensive agents in daily clinical practice.
Journal of clinical hypertension (Greenwich, Conn.) 2001;3(3):139-44.
1998: José L Rodicio; Carlos Campo; Luis M Ruilope
Microalbuminuria in essential hypertension.
Kidney international. Supplement 1998;68():S51-4.
1997: Carlos Campo; O Garcia-Vallejo; V Barrios; Vicente Lahera; M Manero; E Esteban; José L Rodicio; Luis M Ruilope
The natriuretic effect of nifedipine gastrointestinal therapeutic system remains despite the presence of mild-to-moderate renal failure.
Journal of hypertension 1997;15(12 Pt 2):1803-8.
1997: Amado Andrés; José M Morales; Manuel Praga; Carlos Campo; Vicente Lahera; Rafael García Robles; José L Rodicio; Luis M Ruilope
L-arginine reverses the antinatriuretic effect of cyclosporin in renal transplant patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1997;12(7):1437-40.
1996: Luis M Ruilope; Carlos Campo; F Rodriguez-Artalejo; Vicente Lahera; R Garcia-Robles; José L Rodicio
Blood pressure and renal function: therapeutic implications.
Journal of hypertension 1996;14(11):1259-63.
1996: Carlos Campo; Vicente Lahera; R Garcia-Robles; Victoria Cachofeiro; Jose M Alcazar; Amado Andres; José L Rodicio; Luis M Ruilope
Aging abolishes the renal response to L-arginine infusion in essential hypertension.
Kidney international. Supplement 1996;55():S126-8.
1994: José M Morales; MA Muñoz; Carlos Campo; Amado Andres; A Araque; C Alamo; Manuel Praga; Teresa Ortuño; E Hernandez; José L Rodicio
Renal transplantation in older patients with double therapy with optional change to cyclosporine monotherapy: long-term results.
Transplantation proceedings 1994;26(5):2511-2.
1994: Luis M Ruilope; Vicente Lahera; J M Alcázar; Manuel Praga; Carlos Campo; José L Rodicio
Randomly allocated study of the effects of standard therapy versus ACE inhibition on micro-albuminuria in essential hypertension.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1994;12(4):S59-63.
1993: José M Morales; M A Munoz; Gregorio Castellano; Francisco Colina; Antonio Fuertes; Amado Andres; Carlos Campo; A Blasco; E Hernandez; José L Rodicio
Impact of hepatitis C in long-functioning renal transplants: a clinicopathological follow-up.
Transplantation proceedings 1993;25(1 Pt 2):1450-3.
1993: Auxiliadora Mazuecos; P C Ramos Guillen; Carlos Campo; R Sanchez; M A Martinez; Manuel Praga
Chronic renal insufficiency after an episode of macroscopic hematuria in IgA nephropathy.
Nephron 1993;64(3):452-5.
1993: Luis M Ruilope; Carlos Campo; Vicente Lahera
The kidney and arterial hypertension.
Drugs 1993;46 Suppl 2():108-12.
1992: José M Morales; José María Aguado; R Diaz-Gonzalez; E Salto; Amado Andres; Carlos Campo; Manuel Praga; M A Martinez; O Leiva; A Rodriguez-Noriega
Alkaline-encrusted pyelitis/cystitis and urinary tract infection due to corynebacterium urealyticum: a new severe complication after renal transplantation.
Transplantation proceedings 1992;24(1):81-2.
1992: José M Morales; S Sancho; M A Muñoz Cepeda; Amado Andres; Carlos Campo; Jose M Alcazar; José L Rodicio
CyA monotherapy in patients over 50 years of age after renal transplantation: short-term results.
Transplantation proceedings 1992;24(1):37-8.
1992: M Morales; Carlos Campo; Gregorio Castellano; Francisco Colina; Amado Andres; Antonio Fuertes; Manuel Praga; José L Rodicio
Clinical implications of the presence of antibodies to hepatitis C after renal transplantation.
Transplantation proceedings 1992;24(1):78-80.
1992: C Montoyo; Miguel Angel Martínez; Carlos Campo; Auxiliadora Mazuecos; Amado Andrés; Manuel Praga
Nephrotic syndrome and focal glomerulosclerosis in adult polycystic kidney disease.
Nephron 1992;61(1):106-10.
1991: José M Morales; Carlos Campo; E Hernandez; Amado Andres; Manuel Praga; C Montoyo; Teresa Ortuño; J R Mosquera; José L Rodicio
Influence of donor and recipient age on graft survival rate after renal transplantation with a protocol of low CyA doses.
Transplantation proceedings 1991;23(5):2622-3.
1991: Auxiliadora Mazuecos; C Montoyo; Amado Andres; Carlos Campo; Manuel Praga
Absence of anaphylactoid reactions with the combined use of ACE inhibitors and AN69 hemodialysis membranes.
Nephron 1991;59(3):519.
1991: Manuel Praga; Amado Andres; E Hernandez; C Montoyo; Auxiliadora Mazuecos; Carlos Campo; José M Morales; José L Rodicio
Tubular dysfunction in nephrotic syndrome: incidence and prognostic implications.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1991;6(10):683-8.
1991: Luis M Ruilope; L Guerrero; M C Casal; Jose M Alcazar; Carlos Campo; Auxiliadora Mazuecos; M L Fernandez; José L Rodicio
Tolerance to nitrendipine in patients with arterial hypertension accompanying chronic renal failure.
Journal of cardiovascular pharmacology 1991;18 Suppl 1():S71-3.